Inflation eases, but RBA remains cautious

Inflationary pressures eased slightly in October, as many economists had forecast, following a poor result in September and data for the September quarter. However, the improvement is not a cause for great excitement and will not lead the Reserve Bank to change its stance on the risks of "sticky" inflation, heightened expectations, and potential interest rate hikes.

Read More

Chariot’s off to the races

Chariot Corporation (ASX:CC9) witnessed a remarkable 35% increase in its share price yesterday, closing at 70 cents with $700,000 in stock trading volume,. And the positive results have been continuing today, currently trading above 6% higher at 74.5c (2:00pm AEDT). While no new developments were reported today, the recent announcement of the arrival of a drill rig at CC9's flagship Black Mountain Project in Wyoming, USA, has been driving investor interest over the past two weeks.

Read More

Chimeric Therapeutics shows promise in ovarian and pancreatic cancers

Chimeric Therapeutics (ASX:CHM), an Australian company specialising in cell therapy, has reported significant in vitro findings for its chlorotoxin (CLTX) chimeric antigen receptor (CAR) NK cell therapy, CHM 1301. These preclinical results highlight the therapy's notable efficacy against ovarian and pancreatic cancers, suggesting potential advancements in cancer treatment.

Read More

Lithium prospects for Whim Creek: A breakdown from Anax Metals CEO Geoff Laing

Anax Metals (ASX:ANX) CEO, Geoff Laing, discusses the company's flagship Whim Creek Copper Hub, emphasizing its innovative approach and rapid path to production. The conversation delves into scalability, lithium exploration potential, and strategic partnerships, offering insights into Anax Metals' ambitious vision for resource development and polymetallic ventures.

Read More